A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated medieval Europe, killing millions and reshaping societies. But new research suggests its deadly history stretches much further back than previously thought. [...]

Have you ever considered buying a DNA kit for a family member as a special gift, such as Father’s Day? On the surface, it may seem like a good idea, as it allows loved ones or friends to peer into their past and family history; however, psychologists have recently warned against it, as it might have profound psychological implications.

In a new book titled The Psychology of Genealogy, Dr. Susan Moore, a retired Australian university researcher in social and developmental psychology, examines the complex emotions associated with DNA testing and uses real-life case studies to illustrate its psychological impact.

“Should you give DNA kits as gifts? It can be fun, [but] it can be risky,” Moore says in a statement. 

Moore cautions that the psychological impact of DNA testing may be far greater than many people anticipate. These tests can reveal unexpected family secrets, uncover cases of misattributed paternity, disclose donor conception, and even link individuals to hundreds of previously unknown half-siblings or relatives they may not want to be connected with.

“Do first think carefully about how your intended recipient might cope with unexpected outcomes,” Moore says.

“Hobbyist family historians are uncovering joyful and inspiring stories of the past as well as sad and unsettling secrets of their ancestry,” Moore explains. “Records and DNA matches provide boosts, challenges, and even threats to one’s sense of self, and this is occurring at unprecedented levels.”

Unexpected DNA results can deeply impact a person’s sense of self and identity, along with family belonging and dynamics—a phenomenon psychologists call “identity disruption.” Moore’s book highlights cases involving revelations of misattributed parentage, late-discovered adoption, and donor conception uncovered through genetic testing, all of which caused more physical harm than good. 

“At the personal level, these may be findings that cause you great distress, that destabilize your sense of who you are, that initially at least, you would have preferred not to know. Once known, however, they cannot be unknown,” says Moore.

DNA testing has also raised privacy concerns in recent years. A 2023 23andMe data breach exposed millions of users’ genetic information, while financial challenges that DNA companies have faced raise questions about what happens to genetic data if these companies fail.

Surprising statistics show that, presently, over 30 million people have tested their DNA through genealogical services like 23andMe and AncestryDNA. 

Still, for many people, even with data breaches and larger companies buying up DNA data sets, it’s still enticing to buy, as their curiosity seems to outweigh the risks.

“How exciting it can be to discover the identity of an ancestor, solve a family mystery, prove or disprove family ‘legends’ or discover previously unknown living relatives,” Moore says. 

“Indeed, genealogists regularly report elation and joy as they unearth lost relatives, discover the identity of a ‘missing’ ancestor, or otherwise break down ‘brick walls’ (genealogical puzzles that seem to resist solutions due to missing, inaccurate, or hard-to-access records).”

“Curiosity is a great motivator,” Moore adds.

Chrissy Newton is a PR professional and the founder of VOCAB Communications. She currently appears on The Discovery Channel and Max and hosts the Rebelliously Curious podcast, which can be found on YouTube and on all audio podcast streaming platforms. Follow her on X: @ChrissyNewton, Instagram: @BeingChrissyNewton, and chrissynewton.com. To contact Chrissy with a story, please email chrissy @ thedebrief.org.

In the rapidly advancing field of assisted reproductive technologies (ART), subtle biochemical cues during treatment cycles can have profound and lasting impacts on offspring health. A groundbreaking study by Jiang, Wei, Liu, and colleagues, set to appear in Nature Communications in 2026, reveals intricate links between human chorionic gonadotropin (hCG) exposure on the trigger day of ART protocols and enduring epigenetic modifications that influence neurodevelopmental trajectories in children conceived via these methods. This research shines a spotlight on the complex interplay between hormonal interventions during ART and the epigenetic landscape shaping long-term neurodevelopmental outcomes.

At the core of this investigation lies hCG, a glycoprotein hormone traditionally recognized for its critical role in early pregnancy maintenance. It is clinically administered as a trigger to induce final oocyte maturation and subsequent ovulation in ART cycles. Despite its widespread use, the broader biological consequences of hCG administration timing and dosage, particularly regarding the epigenome of resulting embryos and offspring, remain poorly understood. Jiang and colleagues address this knowledge gap by systematically evaluating how hCG exposure on trigger day affects DNA methylation patterns—a key epigenetic mechanism regulating gene expression—in offspring conceived via ART.

Utilizing a large cohort of ART offspring and sophisticated epigenomic profiling techniques, the researchers uncovered that variations in trigger-day hCG levels corresponded to distinct DNA methylation signatures detectable in peripheral tissues of the children years post-birth. These methylation changes were not random but localized to genes with established roles in neurodevelopment and synaptic function. Notably, altered methylation was observed in loci involved in neuronal proliferation, differentiation, and synaptic plasticity, processes fundamental to cognitive development and neurological health.

The implications of these findings are considerable given the rising prevalence of ART-conceived individuals globally. Epigenetic modifications such as DNA methylation are dynamic yet heritable through cell division, and perturbations during critical windows of embryonic development can have cascading effects on gene regulation. Jiang et al.’s data suggest that the timing and hormonal milieu created by hCG administration on trigger day may inadvertently shape the epigenetic program of the embryo with consequences extending into postnatal brain development.

To unravel the potential neurodevelopmental consequences, the team correlated their epigenetic data with standardized neuropsychological assessments performed on the ART offspring. They reported significant associations between specific methylation patterns and measures of cognitive function, executive processing, and social behavior, domains frequently implicated in neurodevelopmental disorders. This links the biochemical intervention in ART directly to behavioral phenotypes observed in the children, underscoring the functional relevance of epigenetic imprinting driven by hCG exposure.

Mechanistically, the study posits that hCG triggers a cascade of intracellular signaling events including modulation of DNA methyltransferase (DNMT) activity and chromatin remodelers during oocyte maturation and early embryo development. These processes may alter the establishment or maintenance of methylation marks at neurodevelopmentally critical genes. Interestingly, variations in the hCG dose and timing created distinct epigenomic landscapes, emphasizing the fine balance required in ART hormone protocols to avoid unintended epigenetic dysregulation.

This research not only advances understanding of ART-associated neurodevelopmental risks but also offers actionable insights for clinical practice. Optimizing hCG administration parameters could mitigate adverse epigenetic and developmental outcomes, enhancing the safety profile of ART. The notion that a single hormonal manipulation at a specific time point can induce persistent epigenomic and neurodevelopmental alterations demands a reevaluation of ART protocols incorporating epigenetic endpoints.

The findings may also have broader implications beyond ART, revealing fundamental principles of how transient hormonal milieus during early development can imprint long-lasting changes on gene regulation and phenotype. This could inform developmental biology, neuroepigenetics, and endocrine research, potentially identifying biomarkers predictive of neurodevelopmental risk across diverse prenatal exposures.

Furthermore, the study leverages cutting-edge epigenomic technologies such as whole-genome bisulfite sequencing and single-cell methylation analysis, coupled with rigorous neurobehavioral phenotyping in a longitudinal cohort framework. This integrative, multi-omics approach sets a new standard for assessing the safety and long-term effects of reproductive interventions, blending molecular precision with clinical relevance.

Ethically, these insights prompt a dialogue about the need for comprehensive monitoring of ART offspring, integrating epigenetic screening and neurodevelopmental surveillance to detect and potentially intervene in early deviations. The epigenetic alterations detected by Jiang et al. are reversible in principle, raising the prospect of targeted epigenetic therapies or nutritional interventions to restore typical developmental trajectories.

Moreover, the study encourages further exploration into paternal contributions and environmental factors interacting with trigger-day hCG effects, recognizing that ART outcomes emerge from a complex interplay of genetics, epigenetics, and external exposures. Identifying modifiers of hCG-induced epigenetic programming could refine personalized ART approaches tailored to individual risk profiles.

Overall, this landmark research by Jiang and colleagues opens a new frontier in reproductive medicine, illustrating that the endocrinology of ART cycles extends beyond immediate gamete maturation to sculpt the epigenomic and neurodevelopmental fate of future generations. It reinforces the imperative for precision medicine in reproductive technologies and highlights the power of epigenetics in mediating early-life environmental influences on human development.

As ART continues to bring hope to millions struggling with infertility, understanding and controlling the subtle molecular ripples of treatment interventions like hCG administration becomes paramount. Jiang et al.’s study sets a vital precedent, demonstrating that optimizing hormone triggers is not merely a matter of improving pregnancy rates but safeguarding the neurological health and well-being of ART-conceived individuals throughout their lives.

Subject of Research: Human chorionic gonadotropin (hCG) effects on DNA methylation and neurodevelopment in offspring conceived via assisted reproductive technologies (ART).

Article Title: Trigger-day hCG effects on DNA methylation and neurodevelopment in ART offspring.

Article References:
Jiang, Y., Wei, X., Liu, X. et al. Trigger-day hCG effects on DNA methylation and neurodevelopment in ART offspring. Nat Commun (2026). https://doi.org/10.1038/s41467-026-74712-7

Image Credits: AI Generated